Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

HST and HST/F promote hair growth and may help treat alopecia.

Compound 15a was effective in inhibiting 5α-reductase.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Bee venom helps hair grow and may work better than some common treatments.

Finasteride effectively blocks enzyme causing male pattern baldness.

Four-amino acid part makes enzyme sensitive to finasteride.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

High doses of finasteride cause cell growth and tumors in mice.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Hair loss drugs may cause sexual issues and infertility in men.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Finasteride doesn't affect sleep spindles in men.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.